Optimizing indinavir regimens.
Youle
M
M
Royal Free Centre for HIV Medicine, Royal Free Hospital, Pond Street, London NW3 2QG, UK.
D018791:CD4 Lymphocyte Count; D002985:Clinical Protocols; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000191:economics / Q000493:pharmacokinetics*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D008297:Male; D019438:Ritonavir / Q000191:economics / Q000493:pharmacokinetics*; D019562:Viral Load
D017320:HIV Protease Inhibitors; D019469:Indinavir; D019438:Ritonavir